Ariz. Admin. Code § R9-6-338 - Emerging or Exotic Disease
A.
Case control measures: A local health agency shall:
1. Upon receiving a report under R9-6-202 or
R9-6-203 of an emerging or exotic disease case or suspect case, notify the
Department within 24 hours after receiving the report and provide to the
Department the information contained in the report;
2. In consultation with the Department,
isolate an emerging or exotic disease case or suspect case as necessary to
prevent transmission;
3. Conduct an
epidemiologic investigation of each reported emerging or exotic disease case or
suspect case; and
4. For each
emerging or exotic disease case, submit to the Department, as specified in
Table 2.4, the information required under
R9-6-206(D).
B. Contact control measures: A
local health agency, in consultation with the Department, shall quarantine or
exclude an emerging or exotic disease contact as necessary, according to
R9-6-303,
to prevent transmission.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
A. Case control measures:
1. For the prevention of gonorrheal ophthalmia, a physician, physician assistant, registered nurse practitioner, or midwife attending the birth of an infant in this state shall treat the eyes of the infant immediately after the birth with one of the following, unless treatment is refused by the parent or guardian:
a. Erythromycin ophthalmic ointment 0.5%; or
b. If erythromycin ophthalmic ointment is not available, another appropriate antibiotic.
2. A local health agency shall comply with the requirements specified in R9-6-1103 concerning treatment and health education for a gonorrhea case that seeks treatment from the local health agency.
B. Contact control measures: If an individual who may have been exposed to gonorrhea through sexual contact with a gonorrhea case seeks treatment for symptoms of gonorrhea from a local health agency, the local health agency shall comply with the requirements specified in R9-6-1103 concerning treatment and health education for the individual.